Munehiro Yoshino

Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens

K. Tsuchiya, Hiroyuki Gatanaga, Natsuo Tachikawa et al. · Biochemical and Biophysical Research Communications · 2004 · 272 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Impact of UGT1A1 gene polymorphisms on plasma dolutegravir trough concentrations and neuropsychiatric adverse events in Japanese individuals infected with HIV-1

Hiroki Yagura, Dai Watanabe, Hiroyuki Kushida et al. · BMC Infectious Diseases · 2017 · 84 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Assessing recovery of renal function after tenofovir disoproxil fumarate discontinuation

Munehiro Yoshino, Hiroki Yagura, Hiroyuki Kushida et al. · Journal of Infection and Chemotherapy · 2011 · 20 citations

Medicine, Nephrology, Pharmacology +7

Development and application of a simple LC-MS method for the determination of plasma rilpivirine (TMC-278) concentrations

Masaaki Shibata, Masaaki Takahashi, Munehiro Yoshino et al. · The Journal of Medical Investigation · 2013 · 20 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Correlation between UGT1A1 polymorphisms and raltegravir plasma trough concentrations in Japanese HIV-1-infected patients

Hiroki Yagura, Dai Watanabe, Misa Ashida et al. · Journal of Infection and Chemotherapy · 2015 · 13 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +11